痰热清注射液辅助治疗小儿支原体肺炎的疗效观察  

Tanreqing Injection in Treatment Efficacy of mycoplasma pneumonia in children

作　　者：王鲁春[1] 华亚军[1] 万俊[1] 

机构地区：[1]东南大学医学院附属江阴医院儿科,江苏江阴214400

出　　处：《临床肺科杂志》2011年第12期1843-1844,共2页Journal of Clinical Pulmonary Medicine

摘　　要：目的探讨痰热清注射液辅助红霉素与阿奇霉素序贯治疗小儿支原体肺炎的临床效果。方法选择60例小儿支原体肺炎患者,随机分为对照组和观察组,每组30例。对照组采用红霉素与阿奇霉素序贯治疗,观察组在对照组的基础上给予痰热清注射液治疗,观察两组患儿疗效以及退热时间、咳嗽及肺部啰音消失时间、X线炎症吸收时间、平均住院时间及不良反应发生情况。结果观察组疗效总有效率显著高于对照组(P<0.05),观察组患儿退热时间、咳嗽及啰音消失时间、X线炎症吸收时间、平均住院时间均较对照组明显缩短(P<0.05),两组不良反应无统计学差异(P>0.05)。结论痰热清注射液改善红霉素与阿奇霉素序贯治疗小儿支原体肺炎的临床疗效。Objective To investigate the clinical effects of Tanreqing Injection combined with erythromycin and azithromycin sequential therapy in treating children with mycoplasma pneumonia.Methods 60 cases of Mycoplasma pneumonia selected from October 2009 to October 2010 were randomly divided into control group and observation group,30 cases in each group.Control group received erythromycin and azithromycin sequential therapy,children in the observation group given Tanreqing injection combined with erythromycin and azithromycin sequential therapy.Clinical effects were observed and the time of fever,cough and pulmonary rales disappeared time,X ray inflammation absorption time,the averager time in hospital and the incidence of adverse reactions were recorded.Results The total effective rates of groups were 73.33% and 86.67%,the difference was statistically significant（P0.05）.And the time for relieving the main symptoms and the averager time in hospital were obviously shorter in observation group than in control group（P0.05）.There was no significant difference in adverse reactions in two groups（P0.05）.Conclusion Tanreqing injection could improve the clinical effects of erythromycin and azithromycin sequential therapy in treating children with MP.

关 键 词：痰热清注射液 肺炎支原体 序贯治疗 疗效 

分 类 号：R725.6[医药卫生—儿科]